Searchable abstracts of presentations at key conferences in endocrinology

ea0056p51 | Adrenal cortex (to include Cushing's) | ECE2018

A descriptive study of patients with adrenocortical carcinoma treated in hospital clinico san carlos (HCSC) over the last 20 years

Barrio Elvira , Ramos Elvira , Miguel Paz de , Diaz J. Angel , Sanabria Concepcion , Cuesta Martin , Jimenez Ines , Espinosa Patricia , Garcia Antonio , Molino Angel

Introduction: Adrenocortical carcinoma (ACC) is a rare and aggressive tumor that accounts for 0.2% of cancer-related deaths. Case series and prospective studies are very limited due to its low prevalence. Current knowledge is based primarily on the opinions of experts in specialized units. The aim of this study is to perform a descriptive analysis of the management and prognosis of patients with ACC in HCSC in the last 20 years.Material and methods: Eigh...

ea0056p300 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Treatment adherence through an Integral Care Program for patients with Metabolic Syndrome in Central Mexico

Munoz-Lopez Daniela Beatriz , Ramos-Borja David , Espino-Reyes Marisol , Reyes-Perez Veronica , Preciado-Puga Monica del Carmen , Gonzalez-Yebra Ana Lilia , Quintana-Vargas Silvia

Introduction: The Metabolic Syndrome (MS) is a cluster of risk factors that are related to cardiovascular disease. In Mexico, the prevalence of MS in adults according to the ENSANUT 2012 is 41%, and it has become a public health problem making it necessary to implement strategies for its management at the lowest cost possible that could encourage adherence to treatment.Objective: To evaluate the effectiveness of a comprehensive care program to achieve an...

ea0056p303 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Improved lipid profile and cardiovascular risk factors after bariatric surgery

Gonzalez Elena , Urioste Ana , Barajas David , Fernandez Paula , Ramos Tania , Alejo Mirian , Hernandez Ana , Garcia Sara , Pintor Begona , Gonzalez Luis , Cano Isidoro , Ballesteros Maria

Background: Bariatric Surgery (BS) is an effective treatment for the metabolic control of obese patients. One of its purposes is to improve the lipid profile and reduce cardiovascular risk.Aims: • To determine the changes in lipid profile and other cardiovascular risk factors before and one year after BS.• To assess differences in lipid parameters depending on the surgical procedure used.• To a...

ea0056p740 | Growth hormone IGF axis - basic | ECE2018

GH replacement therapy (GHRT) in adult patients with GH deficiency (GHD): a long term follow up

Peris Begona Pla , Ramos-Levi Ana Maria , Marijuan Clara , Fernandez Elena , Aguirre Nerea , Mosse Alexia , Jimenez Sara , Hernando Inigo , Vargas Marcos Lahera , Azpiroz Monica Marazuela

Introduction: GH deficiency (GHD) leads to altered body composition, lipid metabolism and quality of life, and is also associated to an increased cardiovascular morbidity and mortality. The aim of this study was to evaluate long-term changes after treatment with GH replacement therapy (GHRT).Methods: We retrospectively reviewed adult patients with GHD in our clinic who were treated with GHRT. We evaluated demographic (etiology, age, dose), anthropometric...

ea0056p754 | Neuroendocrinology | ECE2018

Initiation of tolvaptan therapy for mild/moderate chronic SIADH-induced hyponatremia in a day-ward

Ramos Elvira , Barrio Elvira , Miguel Paz de , Cuesta Martin , Fernandez Luzdivina , Victoria Saez de Parayuelo Maria , Maria Cruz Anba , Ortiz Marta , Calle Alfonso , Runkle Isabelle

Introduction: Tolvaptan is the only V2-receptor antagonist authorized for use in Europe in patients with SIADH. Its initiation requires hospitalization. Our goal was to analyze the safety and efficacy of tolvaptan started in a Hospital Day-Ward.Material and methods: Retrospective descriptive study of 33 ambulatory patients with mild/moderate SIADH-induced chronic sustained hyponatremia initiating tolvaptan therapy in the Day-Ward of a tertiary center ove...

ea0056p1078 | Thyroid (non-cancer) | ECE2018

Diminished levels and defective suppression function of Tr1 cells is observed in patients with autoimmune thyroiditis

Sampedro-Nunez Miguel , Vitales-Noyola Marlen , Serrano-Somavilla Ana , Martinez-Hernandez Rebeca , Aguirre Nerea , Fernandez Elena , Maria Ramos-Levi Ana , Gonzalez-Amaro Roberto , Marazuela Monica

Context: T regulatory type 1 (Tr1) cells are a subpopulation of T lymphocytes (CD4+CD49+LAG-3+IL-10+) lymphocytes that exerts a significant immunosuppressive effect. However, its possible role in autoimmune thyroid disease (AITD) had not been explored so far.Objective: To analyze the levels and function of Tr1 cells in peripheral blood and thyroid tissue of patients with AITD.Design: Cases and controls, observational study.<p c...

ea0073aep38 | Adrenal and Cardiovascular Endocrinology | ECE2021

Low-renin hypertension with normal or high aldosterone levels is a cause of severe hypertension, and can be diagnosed by applying endocrine society hyperaldosteronism guidelines

Xavier Pérez Candel , Ramos Elvira , Barrio Elvira , Jorge Gabriel Ruiz Sánchez , Martín Cuesta Hernández , Pazos Mario , Carreiro Sara Mera , Madrid Blanca Bernaldo , Calle Alfonso , Runkle Isabel

Low-renin hypertension (LRH) with normal or elevated aldosterone levels is considered part of the spectrum of aldosterone-associated hypertension, and can cause poorly-controlled hypertension. We studied patients diagnosed with LRH, comparing their clinical and biochemical characteristics with patients diagnosed with primary hyperaldosteronism (PHA). Methods Retrospective. Diagnosis in a general Endocrinology out-patient clinic ove...

ea0081p68 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Development and validation of a new gestational diabetes mellitus (gdm) risk algorithm

Mendizabal Leire , Arregui Maddi , Valerio Johanna , Ramos Ana Maria , Barabash Ana , de la Torre Nuria Garcia , zulueta mirella , Arana Eunate , Saez Eva , Aranbarri Igotz , Martinez-Lage Juan , Cortazar Alicia , Gaztambide Sonia , Castano Luis , Simon Laureano , Luis Calle-Pascual Alfonso

Background and Objective: Gestational Diabetes Mellitus (GDM) is associated with life-long adverse outcomes for the mother and the baby. To date there is no rigorous clinical test for the assessment of GDM risk, since estimation of GDM risk is currently primarily based on clinical risk factors. Additional markers are needed to identify women at high risk. Our aim was to develop and validate a risk assessment model to identify women at high risk of GDM through an algorithm that...

ea0081ep695 | Pituitary and Neuroendocrinology | ECE2022

Epidemiological description of 20 years of experience in the management of insulinomas in a third level hospital

Maricel Rivas Montenegro Alejandra , Ramos Roberto Jose An ez , Belinchon Sergio Santos , Gonzalez Fernandez Laura , Moreno Diego Mun oz , Fernandez Fernandez Elisa , Salas Marcel Sambo , Hualpa Juan Carlos Percovich , Gonzalez Albarran Olga , Garcia Centeno Rogelio

Introduction: Insulinoma, despite its low incidence of 0.4%, it is the most common functioning pancreatic neuroendocrine tumor. Most are benign, solitary and sporadic. Around 10% can be malignant and 5-10% are part of MEN-1. On certain occasions, the differential diagnosis is difficult when there is a history of Diabetes Mellitus (DM). Our objective was to describe clinical-epidemiological data and its diagnostic-therapeutic management.Materials and Meth...

ea0086p266 | Reproductive Endocrinology | SFEBES2022

Identification of a transcription factor that modulates ERα-Dependent Hypothalamic Estrogen Sensing

Fernandes-Freitas Isabel , Milona Alexandra , Ramos-Pittol Jose , Manchishi Stephen , Rainbow Kara , Lam Brian , Tadross John , Beucher Anthony , Colledge William , Cebola Ines , Murphy Kevin , Miguel-Aliaga Irene , Yeo Giles , Dhillo Waljit , Owen Bryn

Coupling the release of pituitary hormones to the developmental stage of the oocyte is essential for female fertility. It is thought to require estrogen to have simultaneous positive and negative feedback effects on two spatially-distinct regions of the hypothalamus, the arcuate nucleus and ‘AVPV’ nucleus. However, the mechanistic basis for this differential effect is not known. Therefore, we mapped the genomic binding of the estrogen receptor alpha (ERα) in bot...